ArticleBreast cancer research and treatment2016

Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience.

Otto Metzger-Filho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.